A fractional-order bladder cancer model with BCG treatment effect
From MaRDI portal
Publication:2322419
DOI10.1007/s40314-019-0810-zzbMath1463.92017OpenAlexW2919834048MaRDI QIDQ2322419
Publication date: 4 September 2019
Published in: Computational and Applied Mathematics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/s40314-019-0810-z
Related Items (4)
Existence and uniqueness results for sequential \(\psi\)-Hilfer fractional pantograph differential equations with mixed nonlocal boundary conditions ⋮ Fractional-order mathematical model for calcium distribution in nerve cells ⋮ Unnamed Item ⋮ Memory effects on the proliferative function in the cycle-specific of chemotherapy
Cites Work
- Dynamical properties and tumor clearance conditions for a nine-dimensional model of bladder cancer immunotherapy
- The effect of anti-viral drug treatment of human immunodeficiency virus type 1 (HIV-1) described by a fractional order model
- A method for solving differential equations of fractional order
- Numerical solution for multi-term fractional (arbitrary) orders differential equations
- Equilibrium points, stability and numerical solutions of fractional-order predator-prey and rabies models
- Global existence theory and chaos control of fractional differential equations
- Mathematical model of pulsed immunotherapy for superficial bladder cancer
- A fractional-order differential equation model of HIV infection of \(CD4^{+}\) T-cells
- Modeling immunotherapy of the tumor -- immune interaction
- Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis
- A mathematical model of combined \textit{bacillus Calmette-Guerin} (BCG) and interleukin (IL)-2 immunotherapy of superficial bladder cancer
- Mathematical model of BCG immunotherapy in superficial bladder cancer
- Fractional Electrical Impedances in Botanical Elements
- Improving Bacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer by adding interleukin 2 (IL-2): a mathematical model
This page was built for publication: A fractional-order bladder cancer model with BCG treatment effect
